Searchable abstracts of presentations at key conferences in endocrinology

ea0026p665 | Diabetes therapy | ECE2011

Evaluation of long term outcomes of intensive treatment with s.c. insulin infusion (CSII) in type 1 diabetic patients

Gonzalez-Molero I , Dominguez-Lopez M , Rubio E , Carreira M , Ruiz de Adana M S , Gonzalez-Romero S , Machado A , Soriguer F

Introduction: Several studies have shown that treatment with insulin pump is an effective therapy for selected type 1 diabetes. Nevertheless, most of them analyse results in short period of time. The objective of this study is to evaluate long term effects on quality of life (DQOL) and metabolic control of CSII.Material and methods: We did a longitudinal study of type 1 diabetic patients previously treated with multiple daily insulin (MDI) therapy who in...

ea0026p666 | Diabetes therapy | ECE2011

Experience with the use of a real time continuous glucose monitoring system during the simultaneous pancreas kidney transplant in patients with diabetes

Gonzalez-Molero I , Dominguez-Lopez M , Ruiz de Adana M S , Gonzalez-Romero S , Gonzalo-Marin M , Valdes S , Olveira G , Soriguer F

Introduction: Simultaneous pancreas kidney transplant (SPK) is a prime line treatment option in patients with type 1 diabetes and chronic kidney failure. The glucose control during perioperatory period can be a prognostic factor for transplant. Actually, the utility of the continuous glucose monitoring is not well defined. Our objective was to study the utility of a continuous glucose monitoring system during the simultaneous pancreas kidney transplant.M...

ea0016p195 | Diabetes and cardiovascular diseases | ECE2008

K121Q PC-1 gene polymorphism is not associated with postpartum type 2 diabetes in gestacional diabetes mellitus patients

Amalia Jimenez Gonzalez , Constanza Fornieles Gonzalez , Carmen Yeste Doblas Ma , Fernando Escobar Jimenez , Luisa Fernandez Soto Ma

Women suffering gestational diabetes mellitus (GDM) are a risk group for type 2 diabetes. The genetic determinants are not widely known and controversial data exists about association between K121Q PC-1 gene polymorphism and early type 2 diabetes and/or IR.The aim of the study was to investigate the relationship between K121Q PC- 1 gene polymorphism and the glucose metabolic alterations, IR or metabolic syndrome in GDM women in the postpartum period....

ea0056oc9.1 | Thyroid from basics to clinics | ECE2018

Increased urinary iodide precedes hypothyroidism in Dehal1 knockout mice

Gonzalez-Guerrero Cristian , Lucia Federico S. , Alcaina Yago , Gonzalez-Lopez Ana M. , Buno Antonio , Mora Roberto , De Miguel Maria Paz , Moreno Jose C.

Thyroid hormones (TH) synthesis requires iodine, a scarce element whose recycling is mediated by the iodotyrosine dehalogenase (encoded by the DEHAL1 gene) through deiodination of mono- and di-iodotyrosines. In humans, biallelic mutations in DEHAL1 lead to a severe form of congenital hypothyroidism (CH) non detectable by neonatal screening programs, which involves the risk of mental retardation. The timing and triggering factors of this particular type of hyp...

ea0056gp16 | Adrenal Case reports | ECE2018

Pheochromocytoma associated with cutaneous and uterine leiomyomatosis and renal cancer in a patient with a germline mutation in the FH gene

Diaz Marta Moron , Cortes Mauro Boronat , Martin Juan Luis Afonso , Moujir Carolina Fernandez-Trujillo , Lleo Ana Maria Gonzalez , Gonzalez Adriana Ibarra , Martin Nuria Perez , Mogollon Francisco Javier Novoa

Introduction: Most of pheochromocytomas (PCC) and paragangliomas (PGL) are sporadic. However, up to 40% of them have an inherited origin due to germline mutations in at least 15 known PCC/PGL genes, being the VHL and SDHx genes the ones most frequently affected. The fumarate hydratase (FH) is a Kreb’s cycle enzyme encoded by the FH gene.Its inactivating mutations increase intracellular levels of fumarate, leading to tissular pseudohypoxia and transcription of genes involv...

ea0056p303 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Improved lipid profile and cardiovascular risk factors after bariatric surgery

Gonzalez Elena , Urioste Ana , Barajas David , Fernandez Paula , Ramos Tania , Alejo Mirian , Hernandez Ana , Garcia Sara , Pintor Begona , Gonzalez Luis , Cano Isidoro , Ballesteros Maria

Background: Bariatric Surgery (BS) is an effective treatment for the metabolic control of obese patients. One of its purposes is to improve the lipid profile and reduce cardiovascular risk.Aims: • To determine the changes in lipid profile and other cardiovascular risk factors before and one year after BS.• To assess differences in lipid parameters depending on the surgical procedure used.• To a...

ea0081oc10.6 | Oral Communications 10: Diabetes, Obesity, Metabolism and Nutrition 3 | ECE2022

Opposite actions of LEAP-2 and ghrelin in energy homeostasis

Masa Sabela Casado , De Oliveira Diz Tadeu , Miguens Marta Varela , Gonzalez Carlos Dieguez , Carro Sulay Tovar

Liver-expressed antimicrobial peptide 2 (LEAP-2) has been recently characterized as an endogenous GHSR1a antagonist. LEAP-2 is produced mainly in the liver, and it was described that an acute ghrelin administration blocks food intake, GH release and normalize glucose levels during chronic caloric restriction. For this reason, it could be considered as a key endocrine factor in the regulation of systemic energy metabolism. Nevertheless, the exact mechanism of action is still un...

ea0081ep418 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

New-onset diabetes after transplantation (NODAT). A case report

Contreras Pascual Cristina , Gonzalez Lazaro Paloma , Moreno Tirado Antonio , Montero Benitez Maria Zhao , Alvarez Lopez Susana

New-onset diabetes after transplantation (NODAT) is a serious complication after a solid organ transplantation. It has been reported to occur in 4% to 25% of renal transplant recipients, 2.5% to 25% of liver transplant recipients, 40% to 60% of hepatitis C virus (HCV) infection and 2% to 53% of all solid organ transplantations. The diagnosis is performed using unmodified criteria for diagnosing diabetes in the general population and risk factors are the commonly recognized fac...

ea0081ep959 | Thyroid | ECE2022

Graves’ orbitopathy caused by alemtuzumab: a case series

Mendez Muros Mariola , Jesus Garcia Gonzalez Juan , Cuadrado Alberto Torres , Manuel Garrido Hermosilla Antonio

Introduction: Alemtuzumab is a monoclonal antibody targeting the CD52 glycoprotein, which is expressed by most mature leucocytes. In early relapsing-remitting multiple sclerosis (MS) alentuzumab effectively decreases relapse rate and disability progression. However, nearly 50% of the pacients treated with alentuzumab develop secondary autoimmune disorders, being Graves’ disease the most common. The development of thyroid eye disease is unusual.Aims ...

ea0090ep247 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Intake of alpha-lipoic acid (thioctic acid) and insulin autoinmune syndrome. A case report

Urzaiz Leticia Serrano , Trincado Pablo , Diego Patricia De , Gonzalez Wendy Valeria , Lacarta Macarena , Moreno Carlos

A 52-year-old female patient with no previous history of interest, and with no prescribed habitual chronic treatment, was admitted to our hospital to be studied for symptomatic hypoglycemias of one month of evolution. Symptoms consisted of malaise, hunger, tremors and profuse sweating that disappeared with food ingestion. She referred hypoglycemic (up to 40 mg/dl) episodes daily, both in fasting and postprandial periods. She even suffered nocturnal episodes that woke her up. O...